T
Executive Medical Affairs Leader | Oncology Field Medical & MSL Leadership
Hire this person
Send a job offer directly to this candidate
About
Medical Affairs executive with 26+ years of progressive leadership across oncology-focused biopharmaceutical and diagnostics organizations, including Amgen, AstraZeneca, Agilent, Gilead, and Summit Therapeutics. Board-certified oncology pharmacist with an MBA in Biotechnology Management. Built MSL organizations from the very first hire to 30+ professionals, led Medical Affairs for 12 global oncology launches and 24 indication expansions, and supported billion-dollar franchises including Neulasta, Tagrisso, Imfinzi, Lynparza, Trodelvy, and Xgeva/Prolia.
Pairs deep clinical oncology grounding with operational rigor: 18 years on Medical and Commercial Review Committees, multi-million-dollar budget ownership, ISR and KOL strategy, and hands-on leadership of AI integration in field medicine, including AI tools for field coaching, KOL engagement planning, and field intelligence collection at two companies.
Experience spans first-in-class bispecifics, antibody-drug conjugates, targeted therapies, immuno-oncology, supportive care biologics, and a liquid biopsy companion diagnostic, across the U.S., Europe, and Asia-Pacific.
Experience
Head of Field Medical, North America / Europe / Japan - Summit Therapeutics - Miami, Florida
(2026-03)
MSL Team Lead and Field Strategy Team Lead, Pan-Tumor Oncology
- Leads the field medical strategy for ivonescimab, a first-in-class bispecific antibody for EGFR-mutated and first-line NSCLC, at a pre-launch company of 500+ employees.
- Built and scaled two MSL teams and the field strategy function into a 30+ person organization of MSLs, field directors, strategy leads, and the Medical Information lead.
- Own MRC and ISR governance for the field organization across North America, Europe, and Japan, and manage multi-million-dollar budgets.
- Built the competitive intelligence collection platform and promotional speaker bureau governance.
- Led the integration and rollout of AI tools for field coaching, KOL engagement planning, and field intelligence collection, introducing AI-enabled capabilities to the field medical organization.
Executive / Senior Director, MSL Team Lead and Strategy Team Lead - Gilead Sciences - Foster City, California
(2022 - 2026)
GU / GI / Thoracic Oncology / TNBC
- Led field medical through the pre-launch and launch of TRODELVY (sacituzumab govitecan), an antibody-drug conjugate for triple-negative breast cancer, in a highly matrixed, leading pharmaceutical company.
- Directed a 20+ person organization of MSLs, field directors, and strategy leads.
- Managed multi-million-dollar budgets, including ISR, and oversaw MRC/PRC governance.
- Built the competitive intelligence collection platform and promotional speaker bureau governance.
- Led the integration and rollout of AI tools for field coaching, KOL engagement planning, and field intelligence collection, introducing AI-enabled capabilities to the field medical organization.
Head of Global Medical, North America / Europe / Asia, MSL and Medical Information - Agilent Technologies - Santa Clara, California
(2020 - 2022)
Pan-Tumor Hematology-Oncology Diagnostic Scientific Platform
- Led the medical launch of a new oncology diagnostic, the first liquid biopsy NGS companion diagnostic (ctDx FIRST) for KRAZATI (adagrasib) in KRAS G12C NSCLC, at a leading diagnostics company.
- Built the global MSL team across three regions and the medical call centers providing companion diagnostic and in-line diagnostic medical support.
- Led a 20+ person organization for a leading diagnostics company.
Executive / Senior Director, MSL Team, Medical Affairs - AstraZeneca - Gaithersburg, Maryland
(2013 - 2020)
GU / GYN / Thoracic Oncology
- Led pre-launch and launch field medical for Tagrisso (osimertinib, 3rd-generation EGFR TKI), Imfinzi (durvalumab, anti-PD-L1), and Lynparza (olaparib, PARP inhibitor) in a highly matrixed organization.
- Built the oncology MSL team from the beginning and scaled it to 20+ across billion-dollar franchises.
- Oversaw learning & development, ISR, MRC, and compliance governance.
- Managed multi-million-dollar budgets and designed field strategies including KOL management and ISR.
- Received Manager of the Year recognition in 2014 and 2015, the first time this occurred in AstraZeneca Medical Affairs.
Senior Director / Director, MSL West Region, Medical Affairs - Amgen - Thousand Oaks, California
(2008 - 2013)
Pan-Tumor Hematology-Oncology
- Led an 8-to-10-person regional MSL team supporting multiple compounds in solid tumors and hematology across the billion-dollar Xgeva/Prolia franchise, with pre-launch and launch responsibility for Aranesp (darbepoetin alfa), Neulasta (pegfilgrastim), Vectibix (panitumumab), Xgeva (denosumab), Kepivance (palifermin), and Nplate (romiplostim).
Principal MSL, Medical Affairs, Pan-Tumor Hematology-Oncology - Amgen - Thousand Oaks, California
(2004 - 2008)
- Held the highest MSL level, with expanded territory coverage and lead responsibility for new-hire onboarding, while supporting multiple new drug launches and indications.
Senior MSL, Medical Affairs, Pan-Tumor Hematology-Oncology - Amgen - Thousand Oaks, California
(2001 - 2004)
- Began the Amgen field medical career that progressed from MSL to regional director over 12 years.
Staff Clinical Oncology Pharmacist (part-time) - University of Washington / Seattle Cancer Care Alliance - Seattle, Washington
(2000 - 2003)
- Provided clinical pharmacy support in GU, GI, and lung oncology clinics, maintaining direct patient-care experience alongside industry work.
Professional Oncology Services Associate - Immunex Corporation - Seattle, Washington
(1999 - 2001)
Medical Information, Medical Communication, Adverse Events
- Developed Medical Information Letters and field resources; staffed the call center for HCP inquiries and adverse event reporting.
Lead Research Assistant, Investigational Oncology Phase 1-2 Trials - University of Washington / Fred Hutch
(1998 - 1999)
Early Career (part-time)
Pharmacy Inpatient Intern - Group Health Cooperative - Seattle
(1996 - 1998)
Early Career (part-time)
Lead Oncology Research Associate - University of Washington Medical Center / Roosevelt Medical Clinic - Seattle
(1996 - 1998)
Early Career (part-time)
Education
MBA - Technology Management, Biotechnology - University of Washington, Michael G.
Foster
School of Business (2000 - 2002)
Doctor of Pharmacy (cum laude) - University of Washington, School of Pharmacy (1996 - 2000)
Plein Certificate in Geriatric Pharmacy - University of Washington, School of Pharmacy, Plein Center for Aging (1997 - 2000)
B.A.
- Psychology